Oncology Center of Excellence
Richard Pazdur, M.D.
Director, Oncology Center of Excellence
Spotlight
Listen to the FDA Drug Information Soundcast in Clinical Oncology (DISCO), an FDA podcast about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development.
On This Page:
About the Oncology Center of Excellence
The FDA Oncology Center of Excellence leverages the combined skills of regulatory scientists and reviewers with expertise in drugs, biologics, and devices (including diagnostics). This Center of Excellence will help expedite the development of oncology and hematology medical products and support an integrated approach in the clinical evaluation of drugs, biologics, and devices for the treatment of cancer. The OCE works with centers and offices across the FDA; visit Who We Are for more information.
Mission Statement
The mission of the Oncology Center of Excellence is to achieve patient-centered regulatory decision-making through innovation and collaboration.
News & Events
- FDA Oncology Center of Excellence Sessions at ASCO 2017
- Upcoming OCE/Stakeholder Meetings
- Oncologic Drugs Advisory Committee
- Hematology/Oncology Approvals
- Follow @FDAOncology
on Twitter - Listen to the Drug Information Soundcast in Clinical Oncology
OCE Programs
- Precision Oncology Program
- Patient-Focused Drug Development
- Immuno-Oncology
- Pediatric Oncology
- INFORMED
- Oncology Devices and Diagnostics
- Oncology Cell and Gene Therapy
- Oncology Regulatory Affairs
Resources
- Information for Sponsors
- Request an OCE speaker
- Jobs in Oncology/Hematology at FDA
- Physician Request for Single Patient IND for Compassionate or Emergency Use